BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories

05.08.25 12:50 Uhr

Werte in diesem Artikel

FRANKLIN LAKES, N.J., Aug. 5, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its Urology and Critical Care (UCC) and Surgery business units are the first in the medical technology industry to achieve a diamond-level rating for all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative's (HIRC) Resiliency Badging program.

BD Businesses Become First in MedTech to Achieve HIRC’s Diamond Badge Across All Supply Chain Resiliency Categories

"Achieving HIRC's Diamond Status Resiliency Badge recognizes BD's commitment to building a resilient end-to-end supply chain across multiple product categories and our relentless pursuit of process excellence and continuous improvement," said Tony Ezell, executive vice president and president of the Americas region for BD. "Hundreds of millions of patients depend on BD, and this recognition is a testament to the work our team does every day to ensure products arrive on time and in the right quantities."

HIRC is a non-profit health care supply chain trade association founded in 2019 by a group of health care systems and trading partners focused on increasing transparency and resiliency. The Resiliency Badge Program includes a rigorous audit to assess supply chain resiliency, ensuring alignment with HIRC's standards for supply continuity, risk mitigation and operational efficiency. After completing a comprehensive audit, HIRC recognized BD for differentiated resiliency in all domain areas for its Surgery and UCC businesses, including demand planning, supplier management, inventory management, logistics, supply chain visibility, risk management and continency planning, and operational health.

BD was one of the first companies recognized by HIRC after receiving the Transparency Partner Badge in 2023. This diamond-level distinction builds on that recognition and demonstrates BD's ongoing investment in its supply chain and manufacturing operations, including increasing safety stock and capacity to allow greater flexibility for the most critical products and improving order management interfaces so customers have real-time insights into supply and deliveries.

About BD 

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts: 
 
Media:

Investors

Fallon McLoughlin

Adam Reiffe 

BD Corporate Communications

BD Investor Relations 

201.258.0361

201.847.6927   

Fallon.McLoughlin@bd.com

adam.reiffe@bd.com  

 

BD (Becton, Dickinson and Company) Logo (PRNewsfoto/BD (Becton, Dickinson and Company))

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-businesses-become-first-in-medtech-to-achieve-hircs-diamond-badge-across-all-supply-chain-resiliency-categories-302521170.html

SOURCE BD (Becton, Dickinson and Company)

In eigener Sache

Übrigens: Becton, Dickinson und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Becton, Dickinson

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Becton, Dickinson

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Becton, Dickinson & Co. (BD)

Wer­bung

Analysen zu Becton, Dickinson & Co. (BD)

DatumRatingAnalyst
13.05.2019Becton, DickinsonCo (BD) OverweightBarclays Capital
07.12.2018Becton, DickinsonCo (BD) BuyDeutsche Bank AG
16.10.2018Becton, DickinsonCo (BD) Equal WeightBarclays Capital
09.03.2018Becton, DickinsonCo (BD) Market PerformBMO Capital Markets
29.12.2017Becton, DickinsonCo (BD) BuyDeutsche Bank AG
DatumRatingAnalyst
13.05.2019Becton, DickinsonCo (BD) OverweightBarclays Capital
07.12.2018Becton, DickinsonCo (BD) BuyDeutsche Bank AG
09.03.2018Becton, DickinsonCo (BD) Market PerformBMO Capital Markets
29.12.2017Becton, DickinsonCo (BD) BuyDeutsche Bank AG
19.08.2015Becton, DickinsonCo (BD) BuyArgus Research Company
DatumRatingAnalyst
16.10.2018Becton, DickinsonCo (BD) Equal WeightBarclays Capital
03.11.2017Becton, DickinsonCo (BD) Sector PerformRBC Capital Markets
09.05.2016Becton, DickinsonCo (BD) Sector PerformRBC Capital Markets
10.08.2015Becton, DickinsonCo (BD) HoldDeutsche Bank AG
07.08.2015Becton, DickinsonCo (BD) Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Becton, Dickinson & Co. (BD) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen